Is intermittent Theta Burst Stimulation (iTBS) Transcranial Magnetic Stimulation (TMS) helpful in treatment of Body Dysmorphic Disorder (BDD) in people who do not respond to currently available treatments?

St Vincent’s Hospital, Melbourne.0 个研究点目标入组 10 人开始时间: 2015年7月17日最近更新: 2020年1月13日

试验速览

暂无简介。

•18-65 years.
•DSM-5 criteria for BDD, and clinical psychiatric evaluation.
•Treatment refractoriness: no response or insufficient response following at least 2 treatments with a selective serotonin reuptake inhibitor (SSRI) at maximum dosage for at least 12 weeks, plus at least 1 Cognitive-Behavioural Therapy (CBT) trial for a minimum of 16 sessions (Phillips, 2008).
•20 or higher on the BDD version on the Yale-Brown Obsessive Compulsive Scale for Body Dysmorphic Disorder (BDD YBOCS).

•Active substance abuse, neurological disorder including a history of seizures or epilepsy, pregnancy, or any current medical disorder that may affect cerebral metabolism; or acutel suicidality.
•Also: cochlear implants; metallic implants in the brain or elsewhere (splinters, clips, fragments); an implanted neurostimulator (deep brain stimulator, vagal nerve stimulator, epidural/subdural stimulator); cardiac pacemaker or intracardiac line; or medication infusion device.

发起方

St Vincent’s Hospital, Melbourne.